Access Bio, Inc. (KOSDAQ:950130)

Access Bio Revenue

Access Bio had revenue of 3.56B KRW in the quarter ending September 30, 2025, a decrease of -84.48%. This brings the company's revenue in the last twelve months to 54.67B, down -54.47% year-over-year. In the year 2024, Access Bio had annual revenue of 112.46B, down -67.74%.

• Revenue (ttm): 54.67B
• Revenue Growth: -54.47%
• P/S Ratio: 2.17
• Revenue / Employee: 541.25M
• Employees: 101
• Market Cap: 118.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	112.46B	-236.18B	-67.74%
Dec 31, 2023	348.64B	-685.22B	-66.28%
Dec 31, 2022	1.03T	528.75B	104.68%
Dec 31, 2021	505.11B	383.31B	314.71%
Dec 31, 2020	121.80B	78.74B	182.86%